Sanderling Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
158
- Portfolio
-
14
- Exits
-
66
Sanderling Ventures General Information
Description
Sanderling Ventures is a venture capital investment firm that was founded in 1979 and is based in San Mateo, California. The firm prefers to invest in the biotechnology, life sciences, therapeutics and pharmaceuticals, drug delivery, medical devices and instrumentation, diagnostics, medical informatics, healthcare information technology and health care services sectors.
Contact Information
Website
www.sanderling.com
Year Founded
1979
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Limited Partner
Primary Office
- 400 South El Camino Real
- Suite 1200
- San Mateo, CA 94402
- United States
+1 (650) 000-0000
Sanderling Ventures Investments & Acquisitions (158)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycomine | 11-Jun-2021 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 00000 |
| 0000000 | 09-Jun-2021 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000 000000000 |
| 00000000000 | 11-Mar-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | 0000000 000000000 |
| 0000000 | 26-May-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000 000000000 |
| 00000000000 | 22-May-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - General | 000000 000000 00.0 |
| 00000 000000000000 | 10-May-2019 | 0000 00000 | Biotechnology | Out of Business | 000000 000000 00.0 | |
| 00000000000 | 15-Dec-2017 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 0000000 00000 |
| 0000000000 000000 | 23-Aug-2017 | 0000 00000 | 000 | Biotechnology | Out of Business | |
| PreciThera | 27-Jul-2017 | Early Stage VC | 0000 | Biotechnology | Startup | 00000 0000000000 00.0 |
| Sotera Wireless | 17-Jul-2017 | Later Stage VC | 000.00 | Monitoring Equipment | Generating Revenue/Not Profitable | 000000 000000 00.0 |
Sanderling Ventures Exits (66)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ViaCyte | 11-Jul-2022 | Merger/Acquisition | 00000 |
| 00000 000000000000 | 26-Oct-2021 | 000 00 00000000 | |
| 0000000000 000000 | 15-Jun-2021 | 000 00 00000000 | |
| 00000000 | 21-Aug-2020 | 000000000000000000 | 00.000 |
| 000000 00000000000 | 01-Nov-2017 | 000 00 00000000 | |
| 00000 0000000000 | 01-Aug-2017 | 000000000000000000 | 000 |
| 00000000 | 01-Jun-2017 | 0000000000: 000000 | |
| 00000 0000000 | 23-Mar-2017 | 000000000000000000 | |
| Pulsar Vascular | 08-Dec-2016 | Merger/Acquisition | |
| Theregen | 01-Dec-2016 | Out of Business |
Sanderling Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Sanderling Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Sanderling Ventures Team (22)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Michael Dixon | Managing Director | 0 | 0 | San Mateo, CA | |
| Timothy Mills | Managing Director | 00 | 0 | 0 | San Mateo, CA |
| Timothy Wollaeger | Managing Director Emeritus | 00 | 0 | 0 | San Mateo, CA |
| Benjamin McGraw III | Venture Partner | 0 | San Mateo, CA | ||
| Norman Marcus MD | Venture Partner | San Diego, CA |
Sanderling Ventures Co-Investors (23)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Mesa Verde Venture Partners | 2 | 0 |
|
|
|
| Abingworth | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 |
|
|
|
| TPG | 0 | 0 | 0 |
|
|
| The Invus Group | 0 | 0 | 0 |
|
|